Literature DB >> 15348720

Interactions of human osteoprogenitors with porous ceramic following diffusion chamber implantation in a xenogeneic host.

R Gundle1, C J Joyner, J T Triffitt.   

Abstract

Porous calcium phosphate ceramics are useful bone graft substitutes on account of their osteoconductive properties and lack of toxicity, but they lack osteogenicity and are brittle in nature. Osteogenic properties, and increased biomechanical properties, could be induced by combining them with human bone-forming cell populations. Progress has been hampered both by the lack of a suitable experimental assay of in vivo human bone formation and a suitable in vivo test system with which to study such cells in association with biomaterials. Here, trabecular bone-derived cells and marrow stromal fibroblastic cells from four human donors aged between 14 and 27 y have been cultured in vitro then combined with a porous ceramic within diffusion chambers and implanted into athymic mice. Bone and cartilage formation was found within the chambers primed with cells cultured in the continuous presence of dexamethasone and ascorbate. These tissues were found in close apposition to the ceramic, confirming that the material is biocompatible and bioactive. These findings demonstrate both that appropriately primed human-cell populations can express the fully differentiated osteoblastic phenotype in the diffusion-chamber model, and also that this is a useful system in which to test the interactions of such cell populations with putative biomaterials.

Entities:  

Year:  1997        PMID: 15348720     DOI: 10.1023/a:1018538529108

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  31 in total

1.  BONE CELLS: BIOCHEMICAL AND BIOLOGICAL STUDIES AFTER ENZYMATIC ISOLATION.

Authors:  W A PECK; S J BIRGE; S A FEDAK
Journal:  Science       Date:  1964-12-11       Impact factor: 47.728

2.  Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice.

Authors:  G H ALGIRE; J M WEAVER; R T PREHN
Journal:  J Natl Cancer Inst       Date:  1954-12       Impact factor: 13.506

3.  Osteochondral differentiation and the emergence of stage-specific osteogenic cell-surface molecules by bone marrow cells in diffusion chambers.

Authors:  S P Bruder; D Gazit; L Passi-Even; I Bab; A I Caplan
Journal:  Bone Miner       Date:  1990-11

4.  Repair of bone defects with marrow cells and porous ceramic. Experiments in rats.

Authors:  H Ohgushi; V M Goldberg; A I Caplan
Journal:  Acta Orthop Scand       Date:  1989-06

5.  Heterotopic osteogenesis in porous ceramics induced by marrow cells.

Authors:  H Ohgushi; V M Goldberg; A I Caplan
Journal:  J Orthop Res       Date:  1989       Impact factor: 3.494

6.  Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers.

Authors:  A J Friedenstein; R K Chailakhyan; U V Gerasimov
Journal:  Cell Tissue Kinet       Date:  1987-05

7.  Efficacy of hydroxyapatite ceramic as a carrier for recombinant human bone morphogenetic protein.

Authors:  I Ono; H Gunji; F Kaneko; T Saito; Y Kuboki
Journal:  J Craniofac Surg       Date:  1995-05       Impact factor: 1.046

8.  The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells.

Authors:  J Goshima; V M Goldberg; A I Caplan
Journal:  Clin Orthop Relat Res       Date:  1991-08       Impact factor: 4.176

9.  Culture-expanded periosteal-derived cells exhibit osteochondrogenic potential in porous calcium phosphate ceramics in vivo.

Authors:  H Nakahara; V M Goldberg; A I Caplan
Journal:  Clin Orthop Relat Res       Date:  1992-03       Impact factor: 4.176

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

View more
  1 in total

1.  Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells.

Authors:  S C Mendes; J M Tibbe; M Veenhof; S Both; F C Oner; C A van Blitterswijk; J D de Bruijn
Journal:  J Mater Sci Mater Med       Date:  2004-10       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.